[1]刘玉龙,李承志,王晓白,等.ExoSeal血管封堵器在肱动脉高位穿刺点止血中的临床应用[J].介入放射学杂志,2020,29(06):560-563.
 LIU Yulong,LI Chengzhi,WANG Xiaobai,et al.Clinical application of ExoSeal vascular closure device in the hemostasis of“high position” puncture point of brachial artery[J].journal interventional radiology,2020,29(06):560-563.
点击复制

ExoSeal血管封堵器在肱动脉高位穿刺点止血中的临床应用()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
29
期数:
2020年06
页码:
560-563
栏目:
血管介入
出版日期:
2020-06-25

文章信息/Info

Title:
Clinical application of ExoSeal vascular closure device in the hemostasis of“high position” puncture point of brachial artery
作者:
刘玉龙 李承志 王晓白 张 红 李王海 李明月 师贞爱 张 艳
Author(s):
LIU Yulong LI Chengzhi WANG Xiaobai ZHANG Hong LI Wanghai LI Mingyue SHI Zhenai ZHANG Yan.
Department of Vascular Surgery, First Affiliated Hospital of Jinan University, Guangzhou, Guangdong Province 510632, China
关键词:
【关键词】 血管封堵器 肱动脉穿刺 止血 腔内治疗
文献标志码:
A
摘要:
【摘要】 目的 评估ExoSeal血管封堵器在肱动脉“高位”穿刺点止血中应用的安全性和有效性。 方法 53例肱动脉高位穿刺患者[女17例,男36例,平均年龄(75.7±8.9)岁],按不同止血方法分为ExoSeal血管封堵器止血组(ExoSeal组,n=37)和手按压止血组(MC组,n=16)。分析两组间止血时间、术后制动时间和围手术期并发症发生率。术后随访3~12个月,平均(9.8±2.9)个月。 结果 ExoSeal组平均止血时间[(3.3±1.4) min]与MC组[(12.7±3.0) min]相比显著缩短(P<0.05),术后平均制动时间[(3.2±1.2) h]与MC组[(5.9±1.4) h]相比显著缩短(P<0.05)。围手术期ExoSeal组出现皮下血肿(<6 cm)1例,穿刺点渗血1例,并发症发生率为5.4%;MC组出现皮下血肿(<6 cm)1例,穿刺点处假性动脉瘤(瘤径3 mm)1例,穿刺点渗血1例,并发症发生率为18.8%。 结论 ExoSeal血管封堵器应用于肱动脉高位穿刺术后止血安全有效,可明显缩短穿刺点术后止血时间和制动时间。

参考文献/References:

[1] Rahul AS, Ganguli S. Closure of alternative vascular sites, including axillary, brachial, popliteal, and surgical grafts[J]. Tech Vasc Interv Radiol, 2015, 18: 113- 121.
[2] Wong SC, Bachinsky W, Cambier P, et al. A randomized comparison of a novel bioabsorbable vascular closure device versus manual compression in the achievement of hemostasis after percutaneous femoral procedures the ECLIPSE(ensure’s vascular closure device speeds hemostasis trial)[J]. JACC Cardiovasc Interv, 2009, 2: 785- 793.
[3] Norgren L, Hiatt WR, Dormandy JA, et al. Inter- society consensus for the management of peripheral arterial disease (TASC Ⅱ)[J]. Eur J Vasc Endovasc Surg, 2007, 33(Suppl 1): S5- S75.
[4] Franz RW, Tanga CF, Herrmann JW. Treatment of peripheral arterial disease via percutaneous brachial artery access[J]. J Vasc Surg, 2017, 66: 461- 465.
[5] Baudouin CJ, Belli AM, Peck RJ, et al. The complications of high brachial artery puncture[J]. Clin Radiol, 1990, 42: 277- 280.
[6] 卿洪琨, 张小明, 蒋京军, 等. 血管闭合器简介[J]. 介入放射学杂志, 2015, 24:548- 552.
[7] Patel R, Muller- Hulsbeck S, Morgan R, et al. Vascular closure devices in interventional radiology practice[J]. Cardiovasc Intervent Radiol, 2015, 38: 781- 793.
[8] Cox T, Blair L, Huntington C, et al. Systematic review of randomized controlled trials comparing manual compression to vascular closure devices for diagnostic and therapeutic arterial procedures[J]. Surg Technol Int, 2015, 27: 32- 44.
[9] 沈 鑫, 李军荣, 李圣华. Angio- Seal血管封堵器在脑血管病介入诊治中的应用[J]. 介入放射学杂志, 2016, 25: 353- 355.
[10] 刘 欢,李新玲,肖利军,等. ExoSealTM血管封堵器在逆行经股动脉介入诊疗中的应用[J]. 介入放射学杂志, 2017, 26:547- 550.
[11] Rimon U, Khaitovich B, Yakubovich D, et al. The use of ExoSeal vascular closure device for direct antegrade superficial femoral artery puncture site hemostasis[J]. Cardiovasc Intervent Radiol, 2015, 38: 560- 564.
[12] Wang Y, Tang J, Ni JW, et al. A comparative study of TR Band and a new hemostatic compression device after transradial coronary catheterization[J]. J Intervent Med, 2018, 1: 221- 228.
[13] Pieper CC, Wilhelm KE, Schild HH, et al. Feasibility of vascular access closure in arteries other than the common femoral artery using the ExoSeal vascular closure device[J]. Cardiovasc Intervent Radiol, 2014, 37: 1352- 1357.

备注/Memo

备注/Memo:
(收稿日期:2019- 10- 28)
(本文编辑:边 佶)
更新日期/Last Update: 2020-06-16